Table of Content

1 Atypical Hemolytic Uremic Syndrome Drug Market Overview
1.1 Atypical Hemolytic Uremic Syndrome Drug Product Scope
1.2 Atypical Hemolytic Uremic Syndrome Drug Segment by Type
1.2.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 ALN-CC5
1.2.3 CCX-168
1.2.4 ET-006
1.2.5 ETR-001
1.2.6 Mubodina
1.2.7 OMS-72
1.2.8 Others
1.3 Atypical Hemolytic Uremic Syndrome Drug Segment by Application
1.3.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Atypical Hemolytic Uremic Syndrome Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Atypical Hemolytic Uremic Syndrome Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Atypical Hemolytic Uremic Syndrome Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Atypical Hemolytic Uremic Syndrome Drug Price Trends (2016-2027)

2 Atypical Hemolytic Uremic Syndrome Drug Estimates and Forecasts by Region
2.1 Global Atypical Hemolytic Uremic Syndrome Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Atypical Hemolytic Uremic Syndrome Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Region (2016-2021)
2.3 Global Atypical Hemolytic Uremic Syndrome Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Atypical Hemolytic Uremic Syndrome Drug Estimates and Projections (2016-2027)
2.4.2 Europe Atypical Hemolytic Uremic Syndrome Drug Estimates and Projections (2016-2027)
2.4.3 China Atypical Hemolytic Uremic Syndrome Drug Estimates and Projections (2016-2027)
2.4.4 Japan Atypical Hemolytic Uremic Syndrome Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Estimates and Projections (2016-2027)
2.4.6 India Atypical Hemolytic Uremic Syndrome Drug Estimates and Projections (2016-2027)

3 Global Atypical Hemolytic Uremic Syndrome Drug Competition Landscape by Players
3.1 Global Top Atypical Hemolytic Uremic Syndrome Drug Players by Sales (2016-2021)
3.2 Global Top Atypical Hemolytic Uremic Syndrome Drug Players by Revenue (2016-2021)
3.3 Global Atypical Hemolytic Uremic Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Atypical Hemolytic Uremic Syndrome Drug as of 2020)
3.4 Global Atypical Hemolytic Uremic Syndrome Drug Average Price by Company (2016-2021)
3.5 Manufacturers Atypical Hemolytic Uremic Syndrome Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Atypical Hemolytic Uremic Syndrome Drug Market Size by Type
4.1 Global Atypical Hemolytic Uremic Syndrome Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Atypical Hemolytic Uremic Syndrome Drug Price by Type (2016-2021)
4.2 Global Atypical Hemolytic Uremic Syndrome Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Atypical Hemolytic Uremic Syndrome Drug Price Forecast by Type (2022-2027)

5 Global Atypical Hemolytic Uremic Syndrome Drug Market Size by Application
5.1 Global Atypical Hemolytic Uremic Syndrome Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Atypical Hemolytic Uremic Syndrome Drug Price by Application (2016-2021)
5.2 Global Atypical Hemolytic Uremic Syndrome Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Atypical Hemolytic Uremic Syndrome Drug Price Forecast by Application (2022-2027)

6 North America Atypical Hemolytic Uremic Syndrome Drug Market Facts & Figures
6.1 North America Atypical Hemolytic Uremic Syndrome Drug Sales by Company
6.1.1 North America Atypical Hemolytic Uremic Syndrome Drug Sales by Company (2016-2021)
6.1.2 North America Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021)
6.2 North America Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type
6.2.1 North America Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2022-2027)
6.3 North America Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Application
6.3.1 North America Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Application (2022-2027)

7 Europe Atypical Hemolytic Uremic Syndrome Drug Market Facts & Figures
7.1 Europe Atypical Hemolytic Uremic Syndrome Drug Sales by Company
7.1.1 Europe Atypical Hemolytic Uremic Syndrome Drug Sales by Company (2016-2021)
7.1.2 Europe Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021)
7.2 Europe Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type
7.2.1 Europe Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Application
7.3.1 Europe 116 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 116 Sales Breakdown by Application (2022-2027)

8 China Atypical Hemolytic Uremic Syndrome Drug Market Facts & Figures
8.1 China Atypical Hemolytic Uremic Syndrome Drug Sales by Company
8.1.1 China Atypical Hemolytic Uremic Syndrome Drug Sales by Company (2016-2021)
8.1.2 China Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021)
8.2 China Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type
8.2.1 China Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2022-2027)
8.3 China Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Application
8.3.1 China 148 Sales Breakdown by Application (2016-2021)
8.3.2 China 148 Sales Breakdown by Application (2022-2027)

9 Japan Atypical Hemolytic Uremic Syndrome Drug Market Facts & Figures
9.1 Japan Atypical Hemolytic Uremic Syndrome Drug Sales by Company
9.1.1 Japan Atypical Hemolytic Uremic Syndrome Drug Sales by Company (2016-2021)
9.1.2 Japan Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021)
9.2 Japan Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type
9.2.1 Japan Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Market Facts & Figures
10.1 Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales by Company
10.1.1 Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type
10.2.1 Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Atypical Hemolytic Uremic Syndrome Drug Market Facts & Figures
11.1 India Atypical Hemolytic Uremic Syndrome Drug Sales by Company
11.1.1 India Atypical Hemolytic Uremic Syndrome Drug Sales by Company (2016-2021)
11.1.2 India Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021)
11.2 India Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type
11.2.1 India Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Type (2022-2027)
11.3 India Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Application
11.3.1 India Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Atypical Hemolytic Uremic Syndrome Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Atypical Hemolytic Uremic Syndrome Drug Business
12.1 Achillion Pharmaceuticals Inc
12.1.1 Achillion Pharmaceuticals Inc Corporation Information
12.1.2 Achillion Pharmaceuticals Inc Business Overview
12.1.3 Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Products Offered
12.1.5 Achillion Pharmaceuticals Inc Recent Development
12.2 Akari Therapeutics Plc
12.2.1 Akari Therapeutics Plc Corporation Information
12.2.2 Akari Therapeutics Plc Business Overview
12.2.3 Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Products Offered
12.2.5 Akari Therapeutics Plc Recent Development
12.3 Alexion Pharmaceuticals Inc
12.3.1 Alexion Pharmaceuticals Inc Corporation Information
12.3.2 Alexion Pharmaceuticals Inc Business Overview
12.3.3 Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Products Offered
12.3.5 Alexion Pharmaceuticals Inc Recent Development
12.4 Amgen Inc
12.4.1 Amgen Inc Corporation Information
12.4.2 Amgen Inc Business Overview
12.4.3 Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Products Offered
12.4.5 Amgen Inc Recent Development
12.5 ChemoCentryx Inc
12.5.1 ChemoCentryx Inc Corporation Information
12.5.2 ChemoCentryx Inc Business Overview
12.5.3 ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Products Offered
12.5.5 ChemoCentryx Inc Recent Development
12.6 greenovation Biotech GmbH
12.6.1 greenovation Biotech GmbH Corporation Information
12.6.2 greenovation Biotech GmbH Business Overview
12.6.3 greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Products Offered
12.6.5 greenovation Biotech GmbH Recent Development
12.7 Kedrion SpA
12.7.1 Kedrion SpA Corporation Information
12.7.2 Kedrion SpA Business Overview
12.7.3 Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Products Offered
12.7.5 Kedrion SpA Recent Development
12.8 Omeros Corp
12.8.1 Omeros Corp Corporation Information
12.8.2 Omeros Corp Business Overview
12.8.3 Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Products Offered
12.8.5 Omeros Corp Recent Development

13 Atypical Hemolytic Uremic Syndrome Drug Manufacturing Cost Analysis
13.1 Atypical Hemolytic Uremic Syndrome Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Atypical Hemolytic Uremic Syndrome Drug
13.4 Atypical Hemolytic Uremic Syndrome Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Atypical Hemolytic Uremic Syndrome Drug Distributors List
14.3 Atypical Hemolytic Uremic Syndrome Drug Customers

15 Market Dynamics
15.1 Atypical Hemolytic Uremic Syndrome Drug Market Trends
15.2 Atypical Hemolytic Uremic Syndrome Drug Drivers
15.3 Atypical Hemolytic Uremic Syndrome Drug Market Challenges
15.4 Atypical Hemolytic Uremic Syndrome Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Atypical Hemolytic Uremic Syndrome Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Atypical Hemolytic Uremic Syndrome Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Atypical Hemolytic Uremic Syndrome Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Region (2016-2021)
Table 6. Global Atypical Hemolytic Uremic Syndrome Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Atypical Hemolytic Uremic Syndrome Drug Revenue Share by Region (2016-2021)
Table 8. Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Atypical Hemolytic Uremic Syndrome Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Atypical Hemolytic Uremic Syndrome Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Atypical Hemolytic Uremic Syndrome Drug Sales Share by Company (2016-2021)
Table 14. Global Atypical Hemolytic Uremic Syndrome Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Atypical Hemolytic Uremic Syndrome Drug Revenue Share by Company (2016-2021)
Table 16. Global Atypical Hemolytic Uremic Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atypical Hemolytic Uremic Syndrome Drug as of 2020)
Table 17. Global Atypical Hemolytic Uremic Syndrome Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Atypical Hemolytic Uremic Syndrome Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Atypical Hemolytic Uremic Syndrome Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Atypical Hemolytic Uremic Syndrome Drug Sales Share by Type (2016-2021)
Table 23. Global Atypical Hemolytic Uremic Syndrome Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Atypical Hemolytic Uremic Syndrome Drug Sales Share by Type (2022-2027)
Table 26. Global Atypical Hemolytic Uremic Syndrome Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Atypical Hemolytic Uremic Syndrome Drug Revenue Share by Type (2022-2027)
Table 28. Global Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Atypical Hemolytic Uremic Syndrome Drug Sales Share by Application (2016-2021)
Table 31. Global Atypical Hemolytic Uremic Syndrome Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Atypical Hemolytic Uremic Syndrome Drug Sales Share by Application (2022-2027)
Table 35. Global Atypical Hemolytic Uremic Syndrome Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Atypical Hemolytic Uremic Syndrome Drug Revenue Share by Application (2022-2027)
Table 37. Global Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Company (2016-2021)
Table 40. North America Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2016-2021)
Table 44. North America Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2022-2027)
Table 46. North America Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2016-2021)
Table 48. North America Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2022-2027)
Table 62. China Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Company (2016-2021)
Table 64. China Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 66. China Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2016-2021)
Table 68. China Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2022-2027)
Table 70. China Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2016-2021)
Table 72. China Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2022-2027)
Table 98. India Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Company (2016-2021)
Table 100. India Atypical Hemolytic Uremic Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 102. India Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2016-2021)
Table 104. India Atypical Hemolytic Uremic Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type (2022-2027)
Table 106. India Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2016-2021)
Table 108. India Atypical Hemolytic Uremic Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application (2022-2027)
Table 110. Achillion Pharmaceuticals Inc Corporation Information
Table 111. Achillion Pharmaceuticals Inc Description and Business Overview
Table 112. Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Product
Table 114. Achillion Pharmaceuticals Inc Recent Development
Table 115. Akari Therapeutics Plc Corporation Information
Table 116. Akari Therapeutics Plc Description and Business Overview
Table 117. Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Product
Table 119. Akari Therapeutics Plc Recent Development
Table 120. Alexion Pharmaceuticals Inc Corporation Information
Table 121. Alexion Pharmaceuticals Inc Description and Business Overview
Table 122. Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Product
Table 124. Alexion Pharmaceuticals Inc Recent Development
Table 125. Amgen Inc Corporation Information
Table 126. Amgen Inc Description and Business Overview
Table 127. Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Product
Table 129. Amgen Inc Recent Development
Table 130. ChemoCentryx Inc Corporation Information
Table 131. ChemoCentryx Inc Description and Business Overview
Table 132. ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Product
Table 134. ChemoCentryx Inc Recent Development
Table 135. greenovation Biotech GmbH Corporation Information
Table 136. greenovation Biotech GmbH Description and Business Overview
Table 137. greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Product
Table 139. greenovation Biotech GmbH Recent Development
Table 140. Kedrion SpA Corporation Information
Table 141. Kedrion SpA Description and Business Overview
Table 142. Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Product
Table 144. Kedrion SpA Recent Development
Table 145. Omeros Corp Corporation Information
Table 146. Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Omeros Corp Description and Business Overview
Table 148. Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Product
Table 149. Omeros Corp Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Atypical Hemolytic Uremic Syndrome Drug Distributors List
Table 153. Atypical Hemolytic Uremic Syndrome Drug Customers List
Table 154. Atypical Hemolytic Uremic Syndrome Drug Market Trends
Table 155. Atypical Hemolytic Uremic Syndrome Drug Market Drivers
Table 156. Atypical Hemolytic Uremic Syndrome Drug Market Challenges
Table 157. Atypical Hemolytic Uremic Syndrome Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Atypical Hemolytic Uremic Syndrome Drug Product Picture
Figure 2. Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type in 2021 & 2027
Figure 3. ALN-CC5 Product Picture
Figure 4. CCX-168 Product Picture
Figure 5. ET-006 Product Picture
Figure 6. ETR-001 Product Picture
Figure 7. Mubodina Product Picture
Figure 8. OMS-72 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application in 2021 & 2027
Figure 11. Clinic Examples
Figure 12. Hospital Examples
Figure 13. Others Examples
Figure 14. Global Atypical Hemolytic Uremic Syndrome Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Atypical Hemolytic Uremic Syndrome Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 17. Global Atypical Hemolytic Uremic Syndrome Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 18. Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 22. Europe Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Atypical Hemolytic Uremic Syndrome Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Atypical Hemolytic Uremic Syndrome Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Atypical Hemolytic Uremic Syndrome Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India Atypical Hemolytic Uremic Syndrome Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest Atypical Hemolytic Uremic Syndrome Drug Players Market Share by Revenue in Atypical Hemolytic Uremic Syndrome Drug: 2016 & 2020
Figure 33. Atypical Hemolytic Uremic Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global Atypical Hemolytic Uremic Syndrome Drug Revenue Share by Type (2016-2021)
Figure 35. Global Atypical Hemolytic Uremic Syndrome Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global Atypical Hemolytic Uremic Syndrome Drug Revenue Share by Application (2016-2021)
Figure 37. Global Atypical Hemolytic Uremic Syndrome Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type in 2020
Figure 39. North America Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application in 2020
Figure 40. Europe Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type in 2020
Figure 41. Europe Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application in 2020
Figure 42. China Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type in 2020
Figure 43. China Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application in 2020
Figure 44. Japan Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type in 2020
Figure 45. Japan Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application in 2020
Figure 46. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type in 2020
Figure 47. Southeast Asia Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application in 2020
Figure 48. India Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Type in 2020
Figure 49. India Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Atypical Hemolytic Uremic Syndrome Drug
Figure 52. Manufacturing Process Analysis of Atypical Hemolytic Uremic Syndrome Drug
Figure 53. Atypical Hemolytic Uremic Syndrome Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed